Equity Research on Forest Laboratories Inc. and Teva Pharmaceutical Industries Ltd. - Drug Manufacturers Look to Profit From ...
August 30 2012 - 8:15AM
Marketwired
www.ShinesRooms.com has a handpicked team of market professionals
with over 100 years of combined investing experience. Today they
are providing members comprehensive research on the Drug
Manufacturers - Other industry and are offering free analytical
research on
Forest Laboratories Inc. (NYSE:
FRX) and
Teva Pharmaceutical Industries
Limited (NYSE: TEVA). Register with us now to have free access
to these research reports. Simply click on the link below.
http://www.ShinesRooms.com/index.php?_controller=RegisterMember&_method=index
Patent cliffs have certainly taken their toll on a number of
drug manufacturing companies. However, a recent move by branded
drug companies to enter the generic market has allowed them to
recoup some of their losses. Several companies have also been
offering coupons for their branded products that bring down costs.
Get your free reports on Forest Laboratories
Inc. and Teva Pharmaceutical Industries
Limited at
http://www.ShinesRooms.com/index.php?_controller=RegisterMember&_method=index.
There is no commitment to join.
ShinesRooms.com is the Ultimate Trading Environment for
investors. If you are considering owning Forest Laboratories Inc.
and Teva Pharmaceutical Industries Limited then you should sign up
for a free membership and our complimentary reports today. Over the
last 5 years our returns outpaced any of the major indexes. Sign up
today by clicking on the link below to find out what you are
missing.
www.ShinesRooms.com
Strong pipelines and FDA approval are also important for the
industry and companies such as Forest Laboratories Inc. and Teva
Pharmaceutical Industries Limited. Teva recently stated that its
new drug application for its oral contraceptive candidate,
Quartette, was accepted by the FDA. Company news on the generics
front has also been positive, as Teva recently announced the launch
of an authorized generic version of ACTOplusmet®, used to help
improve blood sugar control in adults with type 2 diabetes.
Teva Pharmaceutical Industries Limited report
is accessible for free by registering today at
http://www.ShinesRooms.com/TevaPharmaceuticalIndustriesLimited300812.pdf
Forest Laboratories, along with Almirall, S.A., has also had
recent success with the FDA, as the administration approved
Tudorza™ Pressair™ for the long-term maintenance treatment of
bronchospasm associated with chronic obstructive pulmonary disease.
Forest Laboratories Inc. report is accessible
for free by registering today at
http://www.ShinesRooms.com/ForestLaboratoriesInc300812.pdf
The two Drug Manufacturers - Other stocks
research reports are available for free by signing up now on the
link below.
www.ShinesRooms.com
About Shinesrooms.com
Shine's Rooms is the brain child of David Shine, a 13 year Wall
Street veteran with a stellar track record. For 13 years Shine has
trained thousands of traders to navigate and profit from the
markets. Using cutting edge technology, Shine provides you with a
community in which you can trade alongside Shine and his Team as
they guide you through the market's ever-changing landscape.
To view our disclaimer, visit this link
http://www.shinesrooms.com/disclaimer.html.
Contact Person: Michael Thomas Smith Marketing
Coordinator info@shinesrooms.com
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jul 2023 to Jul 2024